Check out Dr. Dan MacArthur's assessment of the Pacific Biosciences presentation at the Advances in Genome Biology and Technology conference. Also check out Genetic Inferences take on AGBT (yes, they're really original with catchy blog names at the Sanger Institute!). In any case, a friend of mine was raving about Pacific Biosciences a few months ago, so I assumed it would blow up soon.
Categories
- Log in to post comments
More like this
For the past few days I've been avidly following Daniel MacArthur's tweets from the Personal Genome Conference at Cold Spring Harbor(@dgmacarthur #cshlpg).
The Personal Genomics tweets aren't just interesting because of the science, they're interesting because MacArthur and others have started to…
A recent paper in Nature Biotechnology reported the first complete human genome to be sequenced using third-generation, single-molecule sequencing technology. The genome sequenced belongs to one Stephen Quake, co-founder of the biotech company Helicos that developed the Heliscope instrument used…
I couldn't agree more with Bonnie Swoger's sentiment that academic librarians need to stop going to library conferences, although I perhaps might not go that far.
In any case, the last couple of weeks have been pretty fallow blogging weeks for me and I just can't seem to come up with any original…
Not Exactly Pocket Science is a set of shorter write-ups on new stories with links to more detailed takes by the world's best journalists and bloggers. It is meant to complement the usual fare of detailed pieces that are typical for this blog.
Geneticist sequences own genome, finds genetic…
"Many interesting critters have had this treatment, including bonobo, panda and Desmond Tutu (in order of majesty)."
Bloody British blog - he doesn't say whether that's ascending order or descending order.
As a bio-noob, I've often wondered what the fuss is about. Are we just talking about a machine that can economically sequence a whole human genome here?
Presumably the killer app of such technology is to sequence a large number of people and get a statistical version of the genotype-phenotype mapping, so that we can know what treatments, etc will work on a person because we know what worked on other individuals with similar DNA sequences. Or am I missing something here?